Effects of Delayed Hypothermic Machine Perfusion on Kidney Grafts with a Preliminary Period of Static Cold Storage and a Total Cold Ischemia Time of Over 24 Hours.
Aged
Cold Ischemia
Cryopreservation
/ methods
Female
Graft Survival
/ physiology
Hemodynamics
/ physiology
Humans
Hypothermia, Induced
/ methods
Kidney
Kidney Transplantation
/ methods
Male
Middle Aged
Organ Preservation
/ methods
Perfusion
Time Factors
Treatment Outcome
Vascular Resistance
/ physiology
Journal
Annals of transplantation
ISSN: 2329-0358
Titre abrégé: Ann Transplant
Pays: United States
ID NLM: 9802544
Informations de publication
Date de publication:
25 Feb 2020
25 Feb 2020
Historique:
entrez:
26
2
2020
pubmed:
26
2
2020
medline:
29
12
2020
Statut:
epublish
Résumé
BACKGROUND Hypothermic machine perfusion (HMP) appears to exert a reconditioning effect on the ischemic damage of kidney grafts. However, some concerns still remain about its real effectiveness when it is delayed after a preliminary period of static cold storage (SCS) or with prolonged overall cold ischemia time (CIT). MATERIAL AND METHODS The effect of HMP on hemodynamic, metabolic, histological and ultrastructural features of grafts was investigated in 21 single-kidney grafts treated with a delayed HMP after SCS and with a total CIT of over 24 h. RESULTS The mean CIT, SCS, and HMP times were 29 h, 12 h, and 18 h, respectively. Longer SCS was associated with higher vascular resistance and lower arterial flow. In the pre- vs. post-HMP comparison, a significant decrease in arterial resistances and increase of flow were recorded. The hemodynamic improvement was independent of HMP duration. The perfused grafts retained some metabolic activity, with a statistically significant decrease of pH, pO2, and glucose levels, and increase of lactates in the perfusion liquid, by the end of HMP. Longer SCS was associated with higher pH and greater pO2 decrease during HMP. Light microscopy and transmission electronic microscopy revealed no significant variations in nuclear, cytoplasmic, or ultrastructural damage. SCS, HMP, and CIT were not identified as risk factor for delayed graft function or rejection. CONCLUSIONS A delayed and extended HMP can recover the graft hemodynamic function, maintain some metabolic activity, and stabilize the accumulated ischemic damage due to a preliminary SCS.
Identifiants
pubmed: 32094320
pii: 918997
doi: 10.12659/AOT.918997
pmc: PMC7059438
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e918997Références
Transplant Proc. 2019 Nov;51(9):2939-2942
pubmed: 31607625
Am J Transplant. 2011 Oct;11(10):2214-20
pubmed: 21834917
Transpl Int. 2016 Oct;29(10):1117-25
pubmed: 27421771
Lancet. 2004 Nov 13-19;364(9447):1814-27
pubmed: 15541456
Transplantation. 1987 Jun;43(6):827-32
pubmed: 3590300
Br J Surg. 2011 Jul;98(7):943-50
pubmed: 21484774
Transpl Int. 2015 Jun;28(6):665-76
pubmed: 25630347
Transplantation. 2018 Aug;102(8):1344-1350
pubmed: 29570164
Curr Opin Organ Transplant. 2018 Jun;23(3):369-374
pubmed: 29697462
Clin Transplant. 2016 Oct;30(10):1198-1208
pubmed: 27543840
Kidney Int. 2015 Feb;87(2):272-5
pubmed: 25635719
Curr Opin Organ Transplant. 2016 Jun;21(3):294-300
pubmed: 26945319
Artif Organs. 2019 May;43(5):478-489
pubmed: 30282122
Am J Transplant. 2010 Sep;10(9):1991-9
pubmed: 20883534
Br J Surg. 2013 Jul;100(8):991-1001
pubmed: 23754643
N Engl J Med. 2009 Jan 1;360(1):7-19
pubmed: 19118301
Transplant Proc. 2012 Sep;44(7):2207-12
pubmed: 22974956
Transplantation. 2012 Apr 27;93(8):787-93
pubmed: 22441320
Transplantation. 2013 Sep;96(6):538-42
pubmed: 23823654
Artif Organs. 2018 Jul;42(7):714-722
pubmed: 29602202
Transplant Proc. 2018 Jan - Feb;50(1):24-32
pubmed: 29407316
Transplant Rev (Orlando). 2018 Jan;32(1):1-9
pubmed: 28483273